Integrated Filing — IndAS


General information about company
Scrip Code 532321
NSE Symbol ZYDUSLIFE
MSEI Symbol NOTLISTED
ISIN INE010B01027
Name of company ZYDUS LIFESCIENCES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 20-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 09-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 20-May-2025   12:00:00
End date and time of board meeting 20-May-2025   13:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-03-24
Indicate Company website link for updated RPT policy of the Company www.zyduslife.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There has been no default.



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 58196000000 151163000000
Other income 1854000000 6962000000
Total income 60050000000 158125000000
2 Expenses
(a) Cost of materials consumed 7208000000 27871000000
(b) Purchases of stock-in-trade 930000000 3509000000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -1236000000 -1211000000
(d) Employee benefit expense 4763000000 17622000000
(e) Finance costs 1554000000 4639000000
(f) Depreciation, depletion and amortisation expense 1280000000 5239000000
(f) Other Expenses
1 Other expenses 8296000000 28105000000
2 Net loss/ (gain) on foreign currency transactions 508000000 -2096000000
Total other expenses 8804000000 26009000000
Total expenses 23303000000 83678000000
3 Total profit before exceptional items and tax 36747000000 74447000000
4 Exceptional items 0 0
5 Total profit before tax 36747000000 74447000000
6 Tax expense
7 Current tax 8265000000 15825000000
8 Deferred tax 345000000 873000000
9 Total tax expenses 8610000000 16698000000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 28137000000 57749000000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 28137000000 57749000000
17 Other comprehensive income net of taxes 112000000 64000000
18 Total Comprehensive Income for the period 28249000000 57813000000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1006000000 1006000000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 27.96 57.39
Diluted earnings (loss) per share from continuing operations 27.96 57.39
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 27.96 57.39
Diluted earnings (loss) per share from continuing and discontinued operations 27.96 57.39
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 41358000000
Capital work-in-progress 11885000000
Investment property 0
Goodwill 0
Other intangible assets 663000000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 72550000000
Trade receivables, non-current 0
Loans, non-current 41190000000
Other non-current financial assets 919000000
Total non-current financial assets 114659000000
Deferred tax assets (net) 0
Other non-current assets 1457000000
Total non-current assets 170022000000
2 Current assets
Inventories 19521000000
Current financial asset
Current investments 42365000000
Trade receivables, current 81618000000
Cash and cash equivalents 1030000000
Bank balance other than cash and cash equivalents 411000000
Loans, current 1251000000
Other current financial assets 4147000000
Total current financial assets 130822000000
Current tax assets (net) 0
Other current assets 2804000000
Total current assets 153147000000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 323169000000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1006000000
Other equity 210895000000
Total equity attributable to owners of parent 211901000000
Non controlling interest
Total equity 211901000000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 28621000000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 308000000
Total non-current financial liabilities 28929000000
Provisions, non-current 2369000000
Deferred tax liabilities (net) 1456000000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 32754000000
Current liabilities
Current financial liabilities
Borrowings, current 54766000000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 321000000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 11995000000
Total Trade payable 12316000000
Other current financial liabilities 5302000000
Total current financial liabilities 72384000000
Other current liabilities 1087000000
Provisions, current 1179000000
Current tax liabilities (Net) 3864000000
Deferred government grants, Current 0
Total current liabilities 78514000000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 111268000000
Total equity and liabilites 323169000000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement (losses)/ gains on post employment defined benefit plans 5000000 -258000000
2 Net gain/ (loss) on Fair Value through OCI Equity Securities 103000000 270000000
Total Amount of items that will not be reclassified to profit and loss 108000000 12000000
2 Income tax relating to items that will not be reclassified to profit or loss -4000000 -52000000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 112000000 64000000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 74447000000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 4613000000
Adjustments for decrease (increase) in inventories -2648000000
Adjustments for decrease (increase) in trade receivables, current -34648000000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 2624000000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 1121000000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 474000000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 5239000000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 137000000
Adjustments for provisions, non-current 248000000
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -757000000
Adjustments for dividend income 3012000000
Adjustments for interest income 3227000000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -631000000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 641000000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -29826000000
Net cash flows from (used in) operations 44621000000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 13481000000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 31140000000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 3785000000
Cash flows used in obtaining control of subsidiaries or other businesses 3254000000
Other cash receipts from sales of equity or debt instruments of other entities 200000000
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 478000000
Purchase of property, plant and equipment 9049000000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 10782000000
Cash receipts from repayment of advances and loans made to other parties 6367000000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 3012000000
Interest received 3630000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -39423000000
Net cash flows from (used in) investing activities -45036000000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 34591000000
Repayments of borrowings 12928000000
Payments of lease liabilities 17000000
Dividends paid 3024000000
Interest paid 4777000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 13845000000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -51000000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -51000000
Cash and cash equivalents cash flow statement at beginning of period 1081000000
Cash and cash equivalents cash flow statement at end of period 1030000000







Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells LLP Yes 31-Jul-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail
Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 650000 Amount as approved by the Audit Committee. 650000 0 0 Textual Information(1)
2 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 65530000 Amount as approved by the Audit Committee. 65530000 0 0
3 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 131450000 Amount as approved by the Audit Committee. 131450000 0 0
4 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Purchase of goods or services 140000 Amount as approved by the Audit Committee. 140000 0 0
5 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 200000 Amount as approved by the Audit Committee. 200000 0 0
6 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 8670000 Amount as approved by the Audit Committee. 8670000 0 0
7 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 280000 Amount as approved by the Audit Committee. 280000 0 0
8 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Purchase of goods or services 8870000 Amount as approved by the Audit Committee. 8870000 0 0
9 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 15960000 Amount as approved by the Audit Committee. 15960000 0 0
10 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 4720000 Amount as approved by the Audit Committee. 4720000 0 0
11 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 399290000 Amount as approved by the Audit Committee. 399290000 0 0
12 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Purchase of fixed assets 630000 Amount as approved by the Audit Committee. 630000 0 0
13 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Purchase of fixed assets 13530000 Amount as approved by the Audit Committee. 13530000 0 0
14 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 12850000 Amount as approved by the Audit Committee. 12850000 0 0
15 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 40000 Amount as approved by the Audit Committee. 40000 0 0
16 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Purchase of goods or services 790000 Amount as approved by the Audit Committee. 790000 0 0
17 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 807500000 Amount as approved by the Audit Committee. 807500000 0 0
18 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 34720000 Amount as approved by the Audit Committee. 34720000 0 0
19 Zydus Lifesciences Limited Vitely Bio LLP Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 360000 Amount as approved by the Audit Committee. 360000 0 0
20 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3050000 Amount as approved by the Audit Committee. 3050000 0 0
21 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 660000 Amount as approved by the Audit Committee. 660000 0 0
22 Zydus Lifesciences Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 4130000 Amount as approved by the Audit Committee. 4130000 0 0
23 Zydus Lifesciences Limited International Tax & Investment Consultants-Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3030000 Amount as approved by the Audit Committee. 3030000 0 0
24 Zydus Lifesciences Limited Sahyadri Hospitals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 40000 Amount as approved by the Audit Committee. 40000 0 0
25 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 9650000 Amount as approved by the Audit Committee. 9650000 0 0
26 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 49730000 Amount as approved by the Audit Committee. 49730000 0 0
27 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 421800000 Amount as approved by the Audit Committee. 421800000 0 0
28 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 40170000 Amount as approved by the Audit Committee. 40170000 0 0
29 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Reimbursement of Expenses paid 140000 Amount as approved by the Audit Committee. 140000 0 0
30 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses paid 12520000 Amount as approved by the Audit Committee. 12520000 0 0
31 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Reimbursement of Expenses paid 11410000 Amount as approved by the Audit Committee. 11410000 0 0
32 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Reimbursement of Expenses paid 183360000 Amount as approved by the Audit Committee. 183360000 0 0
33 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses paid 81920000 Amount as approved by the Audit Committee. 81920000 0 0
34 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 1640000 Amount as approved by the Audit Committee. 1640000 0 0
35 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Reimbursement of Expenses paid 19200000 Amount as approved by the Audit Committee. 19200000 0 0
36 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 940000 Amount as approved by the Audit Committee. 940000 0 0
37 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses paid 14340000 Amount as approved by the Audit Committee. 14340000 0 0
38 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 30000 Amount as approved by the Audit Committee. 30000 0 0
39 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Reimbursement of Expenses paid 3820000 Amount as approved by the Audit Committee. 3820000 0 0
40 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Reimbursement of Expenses Recovered 5560000 Amount as approved by the Audit Committee. 5560000 0 0
41 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 1260000 Amount as approved by the Audit Committee. 1260000 0 0
42 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 153350000 Amount as approved by the Audit Committee. 153350000 0 0
43 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 130000 Amount as approved by the Audit Committee. 130000 0 0
44 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 410860000 Amount as approved by the Audit Committee. 410860000 0 0
45 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 57370630000 Amount as approved by the Audit Committee. 57370630000 0 0
46 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 1820900000 Amount as approved by the Audit Committee. 1820900000 0 0
47 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Sale of goods or services 275180000 Amount as approved by the Audit Committee. 275180000 0 0
48 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 5160000 Amount as approved by the Audit Committee. 5160000 0 0
49 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 337520000 Amount as approved by the Audit Committee. 337520000 0 0
50 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Sale of goods or services 810100000 Amount as approved by the Audit Committee. 810100000 0 0
51 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Sale of goods or services 602420000 Amount as approved by the Audit Committee. 602420000 0 0
52 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Sale of goods or services 313210000 Amount as approved by the Audit Committee. 313210000 0 0
53 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Sale of goods or services 145100000 Amount as approved by the Audit Committee. 145100000 0 0
54 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 179700000 Amount as approved by the Audit Committee. 179700000 0 0
55 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 1649690000 Amount as approved by the Audit Committee. 1649690000 0 0
56 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 14390000 Amount as approved by the Audit Committee. 14390000 0 0
57 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 1000000 Amount as approved by the Audit Committee. 1000000 0 0
58 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 370000 Amount as approved by the Audit Committee. 370000 0 0
59 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of fixed assets 320000 Amount as approved by the Audit Committee. 320000 0 0
60 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services -13170000 Amount as approved by the Audit Committee. -13170000 0 0
61 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of fixed assets 270000 Amount as approved by the Audit Committee. 270000 0 0
62 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Sale of goods or services 4250000 Amount as approved by the Audit Committee. 4250000 0 0
63 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 9470000 Amount as approved by the Audit Committee. 9470000 0 0
64 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 3060000 Amount as approved by the Audit Committee. 3060000 0 0
65 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 4840000 Amount as approved by the Audit Committee. 4840000 0 0
66 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 1060000 Amount as approved by the Audit Committee. 1060000 0 0
67 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Sale of goods or services 17500000 Amount as approved by the Audit Committee. 17500000 0 0
68 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 178810000 Amount as approved by the Audit Committee. 178810000 0 0
69 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 16250000 Amount as approved by the Audit Committee. 16250000 0 0
70 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 4220000 Amount as approved by the Audit Committee. 4220000 0 0
71 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Sale of goods or services 34890000 Amount as approved by the Audit Committee. 34890000 0 0
72 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 1540000 Amount as approved by the Audit Committee. 1540000 0 0
73 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 30780000 Amount as approved by the Audit Committee. 30780000 0 0
74 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 63670000 Amount as approved by the Audit Committee. 63670000 0 0
75 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 40000 0
76 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Investment 0 N.A. 1395000000 0 1395000000 Investment 0 N.A Unsecured Business Purpose Textual Information(2)
77 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 120000 Amount as approved by the Audit Committee. 120000 0 0
78 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 2400000
79 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 50000 Amount as approved by the Audit Committee. 50000 0 0
80 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Sale of goods or services 210000 Amount as approved by the Audit Committee. 210000 0 0
81 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 66690000 Amount as approved by the Audit Committee. 66690000 0 0
82 Zydus Lifesciences Limited Zynext Ventures Pte. Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 950000 Amount as approved by the Audit Committee. 950000 0 0
83 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0 N.A. 6250000 0 0
84 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0 N.A. 1744500000 0 0 Loan 0.024 5 Year Unsecured Business Purpose Textual Information(3)
85 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 0 1714650000
86 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 299990000 Amount as approved by the Audit Committee. 299990000 0 0
87 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 840000 Amount as approved by the Audit Committee. 840000 0 0
88 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 Amount as approved by the Audit Committee. 0 0 0
89 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 760000 Amount as approved by the Audit Committee. 760000 0 0
90 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 24030000 Amount as approved by the Audit Committee. 24030000 0 0
91 Zydus Lifesciences Limited Mr. Pankaj R. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0 N.A. 600000 0 0
92 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Remuneration 0 N.A. 210000000 0 0
93 Zydus Lifesciences Limited Mr. Ganesh N. Nayak Key Managerial Personnel Remuneration 0 N.A. 70000000 0 0
94 Zydus Lifesciences Limited Mr. Nitin D. Parekh Key Managerial Personnel Remuneration 0 N.A. 47270000 0 0
95 Zydus Lifesciences Limited Mr. Dhaval N. Soni Key Managerial Personnel Remuneration 0 N.A. 2380000 0 0
96 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0 N.A. 110000 0 0
97 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Interest received 0 N.A. 347390000 0 0
98 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Interest received 0 N.A. 242700000 0 0
99 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Interest received 0 N.A. 257350000 0 0
100 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Interest received 0 N.A. 237620000 0 0
101 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 83660000 Amount as approved by the Audit Committee. 83660000 0 0
102 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Interest received 0 N.A. 7030000 0 0
103 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Interest paid 0 N.A. 39350000 0 0
104 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Interest paid 0 N.A. 421430000 0 0
105 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Interest paid 0 N.A. 1399260000 0 0
106 Zydus Lifesciences Limited Zydus Foundation Subsidiary Company Any other transaction Advance for CSR 0 N.A. 203980000 0 0
107 Zydus Lifesciences Limited Zydus Foundation Subsidiary Company Any other transaction Corporate Social Responsibility (CSR) Expenses 0 N.A. 347610000 0 0
108 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Loan 0 N.A. 4661110000 0 0 Loan 0.018 5 Year Unsecured Business Purpose Textual Information(4)
109 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Interest received 0 N.A. 160000 0 0
110 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 4420000 4430000
111 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Investment 0 N.A. 550000000 7050000000 7600000000 Investment 0 N.A Unsecured Business Purpose Textual Information(5)
112 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Investment 0 N.A. 0 83700000 0
113 Zydus Lifesciences Limited Zynext Ventures Pte. Ltd. Subsidiary Company Investment 0 N.A. 436100000 360430000 796530000 Investment 0 N.A Unsecured Business Purpose Textual Information(6)
114 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Loan 0 N.A. 4622590000 0 0
115 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Loan 0 N.A. 1272020000 0 0
116 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Loan 0 N.A. 1742550000 0 0
117 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Loan 0 N.A. 191520000 0 0
118 Zydus Lifesciences Limited Cadila Healthcare Ltd. Managerial Cadre EPF Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 275320000 0 0
119 Zydus Lifesciences Limited Cadila Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 480000000 0 0
120 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 11669800000 11451350000
121 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 36637760000 42346950000
122 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 1037240000 1035420000
123 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 470030000 442420000
124 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 135450000 11350000
125 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 400870000 378920000
126 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 733450000 650170000
127 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 37020000 61940000
128 Zydus Lifesciences Limited Nesher Pharmaceuticals (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 580000 0
129 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 75080000 75220000
130 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 302370000 290540000
131 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 48160000 59570000
132 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 59590000 78890000
133 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 273450000 248550000
134 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 1960000 1640000
135 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 1240000 Amount as approved by the Audit Committee. 1240000 0 0
136 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 1230000 440000
137 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 1100000 0
138 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 87770000 13380000
139 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 9730000 14920000
140 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 15370000 7080000
141 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 61350000 1870000
142 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 650000 210000
143 Zydus Lifesciences Limited Vitely Bio LLP Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 860000 0
144 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 30000 20000
145 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 430000 920000
146 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 140820000 113380000
147 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 24770000 10180000
148 Zydus Lifesciences Limited Aleta Hospitals LLP [Formerly known as Zydus Hospitals (Vadodara) LLP] Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 0
149 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 195620000
150 Zydus Lifesciences Limited Mr. Ganesh N. Nayak Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 81660000
151 Zydus Lifesciences Limited Mr. Nitin D. Parekh Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 2670000
152 Zydus Lifesciences Limited Mr. Dhaval N. Soni Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 220000
153 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 2480000 2550000
154 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 229850000 228050000
155 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 13404710000 12582440000
156 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 13822050000 9396200000
157 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 5445050000 10250400000
158 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 9765210000 8262750000
159 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 204300000 241870000
160 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 3990000 620000
161 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 10530000 1360000
162 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 3920000 5260000
163 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 104340000 74470000
164 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 3280000 1240000
165 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 594900000 294680000
166 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 37989420000 61770210000
167 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 1344150000 1796700000
168 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 46920000 17270000
169 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 290780000 210020000
170 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 841350000 701810000
171 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 907660000 1011860000
172 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 877050000 1371440000
173 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 1254180000 1791170000
174 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 715870000 893400000
175 Zydus Lifesciences Limited Etna Biotech S.R.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 76390000 76390000
176 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 130780000 95520000
177 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 236030000 247580000
178 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 227320000 408560000
179 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 9630000 7530000
180 Zydus Healthcare Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 340000 Amount as approved by the Audit Committee. 340000 0 0
181 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 140000 Amount as approved by the Audit Committee. 140000 0 0
182 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 840000 Amount as approved by the Audit Committee. 840000 0 0
183 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 200000 Amount as approved by the Audit Committee. 200000 0 0
184 Zydus Healthcare Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 1000000 Amount as approved by the Audit Committee. 1000000 0 0
185 Zydus Healthcare Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 62380000 Amount as approved by the Audit Committee. 62380000 0 0
186 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 18410000 Amount as approved by the Audit Committee. 18410000 0 0
187 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 670000 Amount as approved by the Audit Committee. 670000 0 0
188 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 8220000 Amount as approved by the Audit Committee. 8220000 0 0
189 Zydus Healthcare Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0 N.A. 350000 0 0
190 Zydus Healthcare Limited Mr. Nitin D. Parekh Key Managerial Personnel Any other transaction Director Sitting Fees 0 N.A. 400000 0 0
191 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Interest received 0 N.A. 2740000 0 0
192 Zydus Healthcare Limited Zydus Foundation Subsidiary Company Any other transaction Corporate Social Responsibility (CSR) Expenses 0 N.A. 147320000 0 0
193 Zydus Healthcare Limited Zydus Foundation Subsidiary Company Sale of goods or services 140000 Amount as approved by the Audit Committee. 140000 0 0
194 Zydus Healthcare Limited Zydus Foundation Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 100000
195 Zydus Healthcare Limited Zydus Foundation Subsidiary Company Any other transaction Advance for CSR 0 N.A. 150000000 0 0
196 Zydus Healthcare Limited Recon Pharmaceuticals and Investments Subsidiary Company Investment 0 N.A. 901100000 0 0 Textual Information(7)
197 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0 N.A. 6895500000 0 0 Loan 0.0035 5 Year Unsecured Business Purpose Textual Information(8)
198 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Loan 0 N.A. 300000000 0 0 Loan 0.078 2 Month Unsecured Business Purpose Textual Information(9)
199 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Loan 0 N.A. 300000000 0 0
200 Zydus Healthcare Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0 N.A. 420000 0 0
201 Zydus Healthcare Limited Zydus Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 52230000 0 0
202 Zydus Healthcare Limited Zydus Wellness Limited Subsidiary Company Loan 0 N.A. 700000000 0 0 Loan 0.009 1 Year Unsecured Business Purpose Textual Information(10)
203 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 250000
204 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 780000 920000
205 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 330000
206 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 11270000 7590000
207 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 81790000 Amount as approved by the Audit Committee. 81790000 0 0
208 Zydus Wellness Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 710000 Amount as approved by the Audit Committee. 710000 0 0
209 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Loan 0 N.A. 350000000 0 0
210 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Interest paid 0 N.A. 17640000 0 0
211 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 0 358070000
212 Zydus Wellness Limited Zydus Foundation Subsidiary Company Any other transaction Corporate Social Responsibility (CSR) Expenses 0 N.A. 6410000 0 0
213 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 1416760000 Amount as approved by the Audit Committee. 1416760000 0 0
214 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 21120000 Amount as approved by the Audit Committee. 21120000 0 0
215 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of fixed assets 560000 Amount as approved by the Audit Committee. 560000 0 0
216 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 214230000 Amount as approved by the Audit Committee. 214230000 0 0
217 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Interest paid 0 N.A. 340000 0 0
218 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0 N.A. 440000000 0 0
219 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 5810000 Amount as approved by the Audit Committee. 5810000 0 0
220 Zydus Wellness Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0 N.A. 400000 0 0
221 Zydus Wellness Limited Mr. Ganesh N. Nayak Key Managerial Personnel Any other transaction Director Sitting Fees 0 N.A. 400000 0 0
222 Zydus Wellness Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 0 N.A. 7080000 0 0
223 Zydus Wellness Limited Mr. Umesh V. Parikh Key Managerial Personnel Remuneration 0 N.A. 9560000 0 0
224 Zydus Wellness Limited Mr. Nandish P. Joshi Key Managerial Personnel Remuneration 0 N.A. 890000 0 0
225 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Interest received 0 N.A. 19660000 0 0
226 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Interest received 0 N.A. 6640000 0 0
227 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Loan 0 N.A. 52910000 0 0 Loan 0.015 2 Year Unsecured Business Purpose Textual Information(11)
228 Zydus Pharmaceuticals Limited Zydus Pharmaceuticals Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 7280000 0 0
229 Zydus Wellness Limited Zydus Wellness Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 5410000 0 0
230 Zydus Wellness Limited Mr. Tarun Arora Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 310000 0
231 Zydus Wellness Limited Mr. Umesh V. Parikh Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 870000 4990000
232 Zydus Wellness Limited Mr. Nandish P. Joshi Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 110000 0
233 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 2057760000 0
234 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 195730000 243450000
235 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 44100000
236 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 0 440310000
237 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 124240000 0
238 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 20320000 35400000
239 Zydus Wellness Products Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 0 N.A. 1630000 0 0
240 Zydus Wellness Products Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 910000 0 0
241 Zydus Wellness Products Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 0 N.A. 52240000 0 0
242 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0 N.A. 95740000 0 0
243 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0 N.A. 45230000 0 0
244 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0 N.A. 1880000 0 0
245 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0 N.A. 4770000 0 0
246 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 20880000 0 0
247 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Sale of goods or services 0 N.A. 3200000 0 0
248 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 460000 0 0
249 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 70000
250 Zydus Wellness Products Limited Heinz India Private Limited Provident Fund Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 1690000 0 0
251 Zydus Wellness Products Limited Heinz India Private Limited Employee Provident Fund Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 2760000 0 0
252 Zydus Wellness Products Limited Heinz India Private Limited Pension Fund Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 1780000 0 0
253 Zydus Wellness Products Limited Zydus Wellness Sikkim Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 5000000 0 0
254 Zydus Wellness Products Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 1890000 0
255 Zydus Wellness Products Limited Mr. Tarun Arora Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 2830000 0
256 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 187030000 213870000
257 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 30130000 19800000
258 German Remedies Pharma Private Limited German Remedies Pharmaceuticals Private Limited Emp Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0 N.A. 5120000 0 0
259 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0 N.A. 176270000 0 0
260 German Remedies Pharma Private Limited Zydus Foundation Subsidiary Company Any other transaction Corporate Social Responsibility (CSR) Expenses 0 N.A. 12190000 0 0
261 German Remedies Pharma Private Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0 N.A. 50000 0 0
262 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 55790000 2830000
263 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 15970000 0 0
264 Zydus Pharmaceuticals Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 200000 0 0
265 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 0 N.A. 14970000 0 0
266 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 9550000 4710000
267 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 48550000 14970000
268 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 20000 0 0
269 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0 N.A. 0 0 0
270 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 100000 110000
271 Zydus Animal Health and Investments Limited Sterling Biotech Limited Joint Ventures Investment 0 N.A. 207840000 6500000000 6707840000 Investment 0 N.A Unsecured Business Purpose Textual Information(12)
272 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Investment 0 N.A. 0 419100000 0
273 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Investment 0 N.A. 150000000 245000000 0 Investment 0 N.A Unsecured Business Purpose Textual Information(13)
274 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Investment 0 N.A. 395000000 0 0 Textual Information(14)
275 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Interest received 0 N.A. 28560000 0 0
276 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Loan 0 N.A. 371210000 0 0 Loan 0.012 5 Year Unsecured Business Purpose Textual Information(15)
277 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 4380000 0
278 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 3320000 0 0
279 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0 N.A. 877140000 0 0
280 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Interest received 0 N.A. 10750000 0 0
281 Zydus Animal Health and Investments Limited Zydus Foundation Subsidiary Company Any other transaction Corporate Social Responsibility (CSR) Expenses 0 N.A. 18430000 0 0
282 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 50740000 172740000
283 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 20000 20000
284 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 1980000
285 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 418850000 427100000
286 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 646680000 1032920000
287 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 931520000 860150000
288 Recon Pharmaceuticals and Investments Zydus Foundation Subsidiary Company Interest received 0 N.A. 210000 0 0
289 Recon Pharmaceuticals and Investments Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 0 N.A. 3170000 0 0
290 Recon Pharmaceuticals and Investments Zydus Foundation Subsidiary Company Investment 0 N.A. 900000000 0 0 Textual Information(16)
291 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 90360000 0 0
292 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 63230000 0 0
293 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 219240000 0 0
294 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 269900000 0 0
295 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Sale of goods or services 0 N.A. 3080000 0 0
296 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0 N.A. 2570000 0 0
297 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0 N.A. 2570000 0 0
298 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Purchase of goods or services 0 N.A. 4693620000 0 0
299 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 123110000 0 0
300 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 N.A. 686050000 0 0
301 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 2774670000 4356580000
302 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 N.A. 110000 0 0
303 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0 N.A. 8330000 0 0
304 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses Recovered 0 N.A. 440000 0 0
305 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 1540000 0 0
306 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 4170000 0 0
307 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 1530000 0 0
308 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 210000 0 0
309 Zydus Pharmaceuticals (USA) Inc. Mahadev Management Inc. Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 65330000 0 0
310 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Interest received 0 N.A. 6420000 0 0
311 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Interest received 0 N.A. 96290000 0 0
312 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Interest received 0 N.A. 19500000 0 0
313 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Interest received 0 N.A. 2160000 0 0
314 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Interest received 0 N.A. 176300000 0 0
315 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 140000 0 0
316 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Interest received 0 N.A. 690000 0 0
317 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Loan 0 N.A. 42380000 0 0 Loan 0.005 1 Year Unsecured Business Purpose Textual Information(17)
318 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 8380000 51300000
319 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 100000 590000
320 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Loan 0 N.A. 186510000 0 0 Loan 0.005 1 Year Unsecured Business Purpose Textual Information(18)
321 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Loan 0 N.A. 363650000 0 0 Loan 0.005 1 Year Unsecured Business Purpose Textual Information(19)
322 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Loan 0 N.A. 1588920000 0 0 Loan 0.005 1 Year Unsecured Business Purpose Textual Information(20)
323 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Loan 0 N.A. 728940000 0 0 Loan 0.005 1 Year Unsecured Business Purpose Textual Information(21)
324 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Loan 0 N.A. 4699850000 0 0
325 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 15840000
326 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 380000
327 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 18440000 46440000
328 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 88990000
329 Zydus Pharmaceuticals (USA) Inc. Nesher Pharmaceuticals (USA) LLC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 9176360000 0
330 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 6715850000 2765470000
331 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 738080000 941430000
332 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 0 367650000
333 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 6403720000 8119670000
334 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 2310000 32550000
335 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 60890000 8360000
336 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 1390000 4140000
337 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 30270000 32880000
338 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 N.A. 521800000 0 0
339 Zydus Worldwide DMCC Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 N.A. 3740000 0 0
340 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0 N.A. 546490000 0 0
341 Zydus Worldwide DMCC Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0 N.A. 1260000 0 0
342 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Interest received 0 N.A. 25200000 0 0
343 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Interest received 0 N.A. 13550000 0 0
344 Zydus Worldwide DMCC Etna Biotech S.R.L. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 70370000 0
345 Zydus Worldwide DMCC Etna Biotech S.R.L. Subsidiary Company Interest received 0 N.A. 5070000 0 0
346 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Interest received 0 N.A. 2420000 0 0
347 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Loan 0 N.A. 210820000 0 0 Loan 0.0125 5 Year Unsecured Business Purpose Textual Information(22)
348 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 0 215580000
349 Zydus Worldwide DMCC Etna Biotech S.R.L. Subsidiary Company Loan 0 N.A. 21690000 0 0 Loan 0.0125 5 Year Unsecured Business Purpose Textual Information(23)
350 Zydus Worldwide DMCC Zydus International Private Limited Subsidiary Company Interest received 0 N.A. 228830000 0 0
351 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 528440000 552560000
352 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 938380000 982350000
353 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 205570000 0
354 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 1571310000 288210000
355 Viona Pharmaceuticals INC Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 20000 0 0
356 Viona Pharmaceuticals INC Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 20000 10000
357 Viona Pharmaceuticals INC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 440000
358 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0 N.A. 18810000 0 0
359 Zydus Healthcare (USA) LLC Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0 N.A. 3110000 0 0
360 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 70000 0 0
361 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 209550000 213750000
362 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 1070000
363 Zydus Healthcare (USA) LLC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 2470000 200000
364 ZyVet Animal Health Inc Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 200520000 0 0
365 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Purchase of goods or services 0 N.A. 1270000 0 0
366 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 1310000
367 Zydus International Private Limited RIC Chemicals LTD Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 1550000 0 0
368 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Interest received 0 N.A. 5470000 0 0
369 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Interest received 0 N.A. 5420000 0 0
370 Zydus International Private Limited Zydus France, SAS Subsidiary Company Interest received 0 N.A. 8060000 0 0
371 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Interest received 0 N.A. 5710000 0 0
372 Zydus International Private Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Loan 0 N.A. 3716210000 0 0
373 Zydus International Private Limited Zydus Worldwide DMCC Subsidiary Company Loan 0 N.A. 3716210000 0 0
374 Zydus International Private Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Interest received 0 N.A. 238960000 0 0
375 Zydus International Private Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 8801100000 5420500000
376 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0 N.A. 684410000 0 0
377 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0 N.A. 478030000 0 0
378 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 17771190000 17114670000
379 Zydus International Private Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 8946660000 5417160000
380 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 252300000 256110000
381 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 364890000 367850000
382 Zydus International Private Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 449680000 454740000
383 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 334330000 337810000
384 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 320000 0 0
385 Zydus France, SAS Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 820000 0 0
386 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 200000 320000
387 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 439770000 420850000
388 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 53450000 51150000
389 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 0 N.A. 312010000 0 0
390 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 70000 0 0
391 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 3130000 6900000
392 Zydus Pharmaceuticals Mexico SA De CV Zydus Pharmaceuticals Mexico Services Company SA De C.V. Subsidiary Company Purchase of goods or services 0 N.A. 460000 0 0
393 Zydus Healthcare Philippines Inc. RJ Conception Law Office Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 90000 0 0
394 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 460000 0 0
395 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 160000 0 0
396 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 630000 540000
397 Zynext Ventures Pte. Ltd. Zynext Ventures USA LLC Subsidiary Company Investment 0 N.A. 426730000 354140000 780870000 Investment 0 N.A Unsecured Business Purpose Textual Information(24)
398 Zynext Ventures USA LLC Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 760000 0 0
399 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Interest received 0 N.A. 25860000 0 0
400 Zydus Pharmaceuticals UK Ltd. Medsolutions (Europe) Limited Subsidiary Company Interest received 0 N.A. 0 0 0
401 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Interest received 0 N.A. 57340000 0 0
402 Zydus Pharmaceuticals UK Ltd. Oncosol Limited Joint Ventures Interest received 0 N.A. 0 0 0
403 Zydus Pharmaceuticals UK Ltd. LiqMeds Worldwide Limited Subsidiary Company Interest paid 0 N.A. 260000 0 0
404 Zydus Pharmaceuticals UK Ltd. Zydus France, SAS Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 840000
405 Zydus Pharmaceuticals UK Ltd. Oncosol Limited Joint Ventures Loan 0 N.A. 190000 0 0
406 Zydus Pharmaceuticals UK Ltd. Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Loans 0 N.A. 0 210000 0
407 Zydus Pharmaceuticals UK Ltd. Medsolutions (Europe) Limited Subsidiary Company Loan 0 N.A. 220000 0 0
408 Zydus Pharmaceuticals UK Ltd. Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 240000 0
409 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 8950000
410 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 1839760000 1704500000
411 Zydus Pharmaceuticals UK Ltd. LiqMeds Worldwide Limited Subsidiary Company Loan 0 N.A. 19760000 0 0
412 Zydus Pharmaceuticals UK Ltd. LiqMeds Worldwide Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0 N.A. 0 21900000 0
413 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0 N.A. 0 829620000 768630000
414 Zydus Lifesciences Global FZE [UAE] Zydus Lifesciences Limited Parent Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 1044060000 3084410000
415 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0 N.A. 225300000 0 0
416 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 0 N.A. 85220000 0 0
417 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 N.A. 15350000 0 0
418 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 7270000 1210000
419 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 128060000 166450000
420 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0 N.A. 8720000 0 0
421 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 0 N.A. 7390000 0 0
422 LiqMeds Worldwide Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0 N.A. 8790000 0 0
423 LiqMeds Worldwide Limited LiqMeds Lifecare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 110000
424 LiqMeds Worldwide Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 18230000
425 LM Manufacturing Limited Oncosol Limited Joint Ventures Sale of goods or services 0 N.A. 340000 0 0
426 LM Manufacturing Limited Oncosol Limited Joint Ventures Any other transaction Reimbursement of Expenses Recovered 0 N.A. 0 0 0
427 LiqMeds Lifecare Limited Oncosol Limited Joint Ventures Sale of goods or services 0 N.A. 93060000 0 0
428 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0 N.A. 34690000 0 0
429 LiqMeds Worldwide Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 436590000 937450000
430 LiqMeds Worldwide Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 200000 200000
431 LM Manufacturing Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 0 2200000
432 LM Manufacturing Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 6380000 0
433 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 8950000
434 LM Manufacturing Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 8240000 8460000
435 LiqMeds Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 229780000 339860000
436 LiqMeds Limited LiqMeds Worldwide Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 56710000 0
437 LiqMeds Lifecare Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 26450000 36640000
438 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 12700000
439 LiqMeds Lifecare Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 1040000 990000
440 LiqMeds Lifecare Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 10090000 9970000
441 LiqMeds Lifecare Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 3730000 116730000
442 Medsolutions (Europe) Limited LiqMeds Worldwide Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 13350000 12800000
443 Medsolutions (Europe) Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 480000
444 Medsolutions (Europe) Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0 N.A. 0 480000 0
445 Zydus Medtech Private Limited Zydus Medtech France SAS Subsidiary Company Investment 0 N.A. 100000 0 100000 Investment 0 N.A Unsecured Business Purpose Textual Information(25)
446 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0 N.A. 1770000 0 0
447 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0 N.A. 1268550000 0 0 Loan 0.0125 1 Month Unsecured Business Purpose Textual Information(26)
448 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0 N.A. 1268550000 0 0
449 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses paid 0 N.A. 37170000 0 0
450 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0 N.A. 0 0 1248650000
451 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of fixed assets 0 N.A. 1183980000 0 0
452 Zydus Healthcare S.A. (Pty) Ltd DI Consultancy Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0 N.A. 7630000 0 0
453 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0 N.A. 1970000000 0 0
454 Zydus Foundation AIA Engineering Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Contributions received 0 N.A. 5100000 0 0
455 Zydus Foundation Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Contributions received 0 N.A. 2160000 0 0
456 Zydus Foundation Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Contributions received 0 N.A. 9950000 0 0
457 Zydus Foundation Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Contributions received 0 N.A. 4120000 0 0
458 Zydus Foundation Zydus Takeda Healthcare Private Limited Joint Ventures Any other transaction Contributions received 0 N.A. 25000000 0 0
Total value of transaction during the reporting period 136068670000



Text Block
Textual Information(1) Receivables / Payables other than loans represents combined balance against sales / purchase pertaining to goods/ propoerty, plant and equipment / various services / reimbursement of expenses. Hence shown separately.
Textual Information(2) Purchase / Subscription of Investments. Opening and closing balance are not given where there was no transaction of Investment during the half year ended March 31, 2025.
Textual Information(3) Loan Given 6 Month SOFR + 240 BPS
Textual Information(4) Loan Given 1 Month SOFR + 180 BPS
Textual Information(5) Purchase / Subscription of Investments.
Textual Information(6) Purchase / Subscription of Investments.
Textual Information(7) Sale /Transfer / Redemption of Investments.
Textual Information(8) Loan Given 1 Month T Bill + 35 BPS
Textual Information(9) Loan Given
Textual Information(10) Loan Given 1 Year T bill + 90 bps
Textual Information(11) Loan Given 6 Month SOFR + 150 BPS
Textual Information(12) Purchase / Subscription of Investments.
Textual Information(13) Purchase / Subscription of Investments.
Textual Information(14) Sale /Transfer / Redemption of Investments.
Textual Information(15) Loan Given 1 Month T Bill + 120 BPS
Textual Information(16) Sale /Transfer / Redemption of Investments.
Textual Information(17) Loan Given 3 Month SOFR + 50 BPS
Textual Information(18) Loan Given 6 Month SOFR + 50 BPS
Textual Information(19) Loan Given 6 Month SOFR + 50 BPS
Textual Information(20) Loan Given 6 Month SOFR + 50 BPS
Textual Information(21) Loan Given 6 Month SOFR + 50 BPS
Textual Information(22) Loan Given 6 Month EURIBOR + 125 BPS
Textual Information(23) Loan Given 6 Month SOFR + 125 BPS
Textual Information(24) Purchase / Subscription of Investments.
Textual Information(25) Purchase / Subscription of Investments.
Textual Information(26) Loan Given 1 Month SOFR + 125 BPS


Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt